Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
buy vibrator.
Popular Articles

Major European Project Lead By Sahlgrenska Academy To Focus On Obesity
The new project is an interdisciplinary research project covering the neurobiological and socio-psychological causes of obesity. It has been awarded EUR 6 million from the EU, corresponding to just over SEK 60 million. The project will gather scientists from seven countries, and will be co-ordinated from the Sahlgrenska Academy.
pharmacy online
Health Subcommittee Considers Bill To Eliminate Pre-Emption For Medical Devices
The House Energy and Commerce Health Subcommittee on Tuesday heard testimony on the Medical Device Safety Act of 2009 (HR 1346), which would allow consumers to sue medical device manufacturers in state courts, CQ HealthBeat reports. The bill responds to last year"s Supreme Court ruling that says medical devices with FDA pre-marketing approval can be pre-empted from lawsuits under state law, in accordance with the Medical Device Amendments of 1976. Rep. Frank Pallone (D-N.Y.), who introduced the bill, said that the 2008 Supreme Court ruling "ignor[ed] congressional intent" by providing blanket immunity for medical device makers. According to Rep. John Dingell (D-Mich.), a co-sponsor of the bill, the original 1976 law sought to grant regulatory authority to FDA for medical devices, but it did not aim to eliminate state liability. Committee Chair Rep. Henry Waxman (D-Calif.), another co-sponsor, said last year"s ruling already has caused 1,400 injury cases to be thrown out of court, adding that the threat of litigation provides manufacturers with additional safety incentives. David Vladeck -- a law professor at Georgetown University Law Center who testified at the hearing -- added that immunity from lawsuits "removes incentive to manufacturers to fix devices quickly and get defective devices off the market."Rep. Nathan Deal (R-Ga.) said the class of device that must obtain pre-marketing approval -- which includes pacemakers and replacement heart valves -- represents only 2% of all approved medical devices each year. Rep. Michael Burgess (R-Texas) added that the measure could create an inconsistent system that allows both FDA experts and jurors in various states to make decisions on medical device safety standards. In addition, Rep. Joe Pitts (R-Pa.) cautioned that the bill might encourage manufacturers to limit distribution of their devices to certain states (Kim, CQ HealthBeat, 5/13). Related Editorial
News of the day
Doctors Struggle To Find Teaching Time, Australia
Due to workforce shortages, doctors are struggling to maintain their involvement in teaching and in research activities, according to an article published in the Medical Journal of Australia. Further, the demands for doctors to teach medical students and doctors-in-training are increasing, with even more medical students now enrolled.
Diagnostics

Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers To Expand Capacity For Asian 100 Genome Project

Illumina (NASDAQ:ILMN) announced that the Genomic Medicine Institute (GMI) at Seoul National University College of Medicine in Korea, purchased seven additional Illumina Genome AnalyzerIIx sequencing systems, expanding the capacity of their recently established Asian Genome Center to 10 Illumina sequencing systems. "GMI"s decision to add seven additional Genome Analyzers is further validation that our sequencing platform is delivering leading performance with its unmatched rate of daily output, ease of use and proven paired-end sequencing capabilities," said Tim Orpin, general manager of Illumina"s Asia Pacific Region. Dr. Jeong-Sun Seo, director of the Genomic Medicine Institute, and his team, have completed a deep sequencing project of the Korean genome and the work was published online in Nature July 8, 2009. "This publication demonstrates the global competitiveness of GMI"s technological capabilities and provides a practical example of Korean bio-medical excellence," said Dr. Seo. GMI is the second largest Genome Center in Asia and the largest center that focuses exclusively on human genome analysis and its clinical application in Asia. As part of the Asian 100 Genome Project, GMI plans to complete the whole genome analysis of 100 Asian individuals by 2012 and establish an Asian Genome Database with comprehensive genome information specifically targeting Asian populations. About the Illumina Genome Analyzer Designed for facilities of all sizes, the Illumina Genome Analyzer has been adopted across genome centers worldwide, plus individual research labs, core and service facilities, and biotechnology and pharmaceutical companies. Generating over 20 Gigabases of sequence data, the Genome Analyzer offers the highest rate of daily output and the simplest and most user-friendly workflow. The Genome Analyzer also offers the broadest set of supported applications, including those used to profile and discover novel transcripts, to create a high-resolution genome-wide map of DNA-protein binding sites and to sequence entire human genomes to greater than 30x coverage. For more information about the Genome Analyzer and to read what customers are doing with Illumina"s sequencing technology, please visit http://www.illumina.com/sequencing. Illumina


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009